Drug Trial Radar · NCT04418765
A Study to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Participants That Are Not Helped by Previous Preventive Treatments
Last checked: Nov 20, 2026Latest source record: Sep 29, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
892
Actual
Start
Jun 1, 2020
Primary completion
Jul 15, 2021
Study completion Sep 15, 2022
Sponsor
- Lead sponsor
- H. Lundbeck A/SIndustry
- Sponsor type
- Industry
- First posted
- Jun 5, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Evaluation of eptinezumab in the prevention of migraine in participants with unsuccessful prior preventive treatments.
Conditions
- Migraine
Interventions
EptinezumabDrug
Eptinezumab, concentrate for solution for infusion 100 mg/milliliter (mL)
PlaceboDrug
concentrate for solution for infusion, intravenously
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in the Number of Monthly Migraine Days (MMDs) Averaged Over Weeks 1 to 12Time frame: Baseline, Weeks 1 - 12
Locations
138 sites in 17 countries. Site status is shown where the registry gives one.
Diablo Clinical Research
Walnut Creek, California
Sarkis Clinical Trials - Gainesville
Gainesville, Florida
Accel Research Sites - Maitland
Maitland, Florida
Michigan Headache and Neurological Institute
Ann Arbor, Michigan
Clinical Research Institute Inc. - Minneapolis
Minneapolis, Minnesota
Albuqerque Clinical Trials
Albuquerque, New Mexico
Dent Neurologic Institute - Amherst
Amherst, New York
Integrative Clinical Trials
Brooklyn, New York
CTI Clinical Research Center
Cincinnati, Ohio
Hometown Urgent Care & Occupational Health/Hometown Research - Huber Heights
Dayton, Ohio
Lynn Health Science Institute - Oklahoma City
Oklahoma City, Oklahoma
Clinical Neuroscience Solutions - Memphis
Memphis, Tennessee
Northwest Clinical Research Center (NWCRC)
Bellevue, Washington
Northwest Neurological
Spokane, Washington
Universitair Ziekenhuis Brussel
Brussels, Brussels Capital, Belgium
Jessa Ziekenhuis - Campus Virga Jesse
Hasselt, Limburg, Belgium
Universitair Ziekenhuis Gent
Ghent, Oost-Vlaanderen, Belgium
Algemeen Ziekenhuis Sint-Jan Brugge-Oostende - Campus Sint-Jan
Bruges, West-Vlaanderen, Belgium
Multiprofile Hospital for Active Treatment Heart and Brain EAD
Pleven, Bulgaria
Medical Center - Teodora EOOD
Rousse, Bulgaria
Acibadem City Clinic Tokuda Hospital
Sofia, Bulgaria
Medical Center Medica Plus
Veliko Tarnovo, Bulgaria
Multiprofile Hospital for Active Treatment in Neurology and Psychiatry Sveti Naum
Sofia, Sofia-Grad, Bulgaria
First Multiprofile Hospital for Active Treatment - Sofia
Sofia, Sofia-Grad, Bulgaria
Nemocnice Jihlava
Jihlava, Czechia
Neurosanatio s.r.o
Litomyšl, Czechia
Neurologie, MP-neuro s.r.o., poliklinika Modry pavilon
Slezská Ostrava, Czechia
NeuroMed Zlín s.r.o.
Zlín, Czechia
MUDr. Helena Hojdíkova s.r.o. Neurologicka Ambulance
Hradec Králové, Hradec Kralové, Czechia
Vestra Clinics
Rychnov nad Kněžnou, Hradec Kralové, Czechia
CCR Brno
Brno, Jihormoravsky Kraj, Czechia
Fakultni nemocnice Ostrava
Ostrava-Poruba-Poruba, Moravian-Silesian, Czechia
CCR Prague
Prague, Prague, Czechia
Fakultní Thomayerova nemocnice
Prague, Prague, Czechia
Neurologicka Ambulance - Forbeli
Prague, Prague, Czechia
Neuropsychiatrie S.R.O.
Prague, Prague, Czechia
Institut Neuropsychiatrické Péce
Prague, Prague, Czechia
CCR Ostrava
Ostrava, Severomoravsky Kraj, Czechia
Fakultní Nemocnice u sv. Anny v Brne
Brno, South Moravian, Czechia
Sydvestjysk Sygehus - Esbjerg
Esbjerg, Denmark
Showing 40 of 138 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.